APRNs Impacted by Opioid Legislation Agreement Announced by Committee Leaders
Yesterday, the Senate and House conference committee agreed on sweeping legislation to combat the opioid epidemic. As a part of this agreement, the legislation (HR6) will include Clinical Nurse Specialists (CNS) as providers authorized to prescribe medication assisted treatment (MAT) for opioid use disorder through October 1, 2023. The agreement also permanently authorizes Nurse Practitioners to prescribe MAT. This bill now will move quickly through both chambers of Congress and then be presented to the President for his signature.
The relevant provision is in Section 3201 of the bill on page 128. It includes:
- Eliminating the sunset date affecting NP and PA ability to prescribe MAT
- Authorizing Clinical Nurse Specialists, Clinical Nurse Midwives, and Certified Registered Nurse Anesthetists to prescribe MAT through Oct. 1, 2023. This makes them "qualified providers" of MAT through that date as long as allowed by their state scope of practice
You can view the full text of the legislation here.